Skip to content
Recall Observatory FDA recall evidence

Drug product

Bevacizumab (Avastin) 2.5mg/0.1mL PF Inj., 0.1 mL syringe, Compounded by Leiter's Compounding Pharmacy, 1700 Park Ave., # 30, San Jose, CA 95126

D-1040-2013

August 26, 2013

Class II

Product summary

Firm
Leiter's Pharmacy
Event
Event 66103
Status
Terminated
Classification
Class II
Quantity
265 vials
Official record key
drug-enforcement:D-1040-2013

Official wording

Reason: Lack of Assurance of Sterility: Leiter Pharmacy is recalling due bacterial contamination found after investigation at contract testing laboratory discovered that OOS/failed results were reported to customers as passing. Hence the sterility of the products cannot be assured.

Code information: Lot #: 08052013@1, 08052013@4, Exp 11/03/2013

Distribution pattern: Nationwide

Derived failure modes

  • Microbial contamination

    reason.microbial_contamination · v1.0.0

    bacterial contamination
  • Sterility assurance

    reason.sterility_assurance · v1.0.0

    Lack of Assurance of Sterility